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Abstract: The biochemical and pharmacological character- 
istics of receptor-stimulated phosphoinositide (PPI) hydrolysis 
in human SK-N-MC neuroepithelioma cells have been ex- 
amined. Of 11 ligands tested, the addition of four, i.e., nor- 
epinephrine, oxotremorine-M, endothelin- 1, and ATP, each 
resulted in an increased release (three- to eightfold) of inositol 
phosphates from [3H]inositol-prelabeled cells. Agonist-stim- 
ulated PPI turnover was sustained for at least 30 min and 
required the addition of Ca2+ for full effect. An increased 
release of inositol phosphates could also be elicited by the 
addition of the Ca” ionophore, ionomycin. All four agonists 
enhanced the release of radiolabeled inositol mono- and bis- 
phosphates, inositol 1,3,4-trisphosphate, and inositol tetra- 
kisphosphate. Increases in inositol 1,4,5-trisphosphate were 
smaller and only consistently observed in the presence of 
norepinephrine or oxotremorine-M. Norepinephnne-stim- 
ulated PPI turnover was potently inhibited by prazosin, WB- 
4 101, and 5-methylurapidil (Ki < 2.5 nM), but was relatively 
insensitive to chloroethylclonidine pretreatment. This phar- 
macological profile is consistent with the involvement of an 
alA-receptor subtype. The presence of an MI muscarinic 
cholinergic receptor is also indicated, because pirenzepine 
blocked oxotremorine-M-stimulated inositol phosphate re- 
lease (Ki = 35 nM) with a 30-fold greater potency than the 
M2-selective antagonist, AF-DX 116. Ofthe three endothelins 
tested, only the addition of endothelin-1 and endothelin-2 
promoted PPI hydrolysis, whereas endothelin-3 was essen- 
tially inactive. A P2 nucleotide receptor of broad agonist 
specificity is also present on these cells and activates PPI 
turnover in the absence of a generalized increase in plasma 
membrane permeability. These results indicate that SK-N- 
MC cells express at least four PPI-linked receptors. Because 
the functional coupling of three of these receptors, i.e., aIA- 
adrenergic, endothelin, and Pz nucleotide, has not been ex- 
tensively characterized previously in neural tissues, the SK- 
N-MC cell line may provide a useful model system for studies 
of these receptors and their regulation. Key Words: Phos- 
phoinositide hydrolysis-Neuroepithelioma-M1 muscarinic 
cholinergic receptor-alA-Adrenergic receptor-P2 nucleo- 
tide receptor-Endothelin. Fisher S. K. and Landon R. E. 
Identification of multiple phosphoinositide-linked receptors 
on human SK-N-MC neuroepithelioma cells. J. Neurochem, 
57, 1599-1608 (1991). 
The CNS and other neural-related tissues possess a 
large number of pharmacologically distinct receptors 
coupled to phosphoinositide (PPI) hydrolysis. Activa- 
tion of these receptors elicits a phosphodiesteratic 
breakdown of phosphatidylinositol 4,5-bisphosphate 
with the concomitant formation of two intracellular 
second messengers, diacylglycerol and inositol 1,4,5- 
trisphosphate (for review, see Fisher and Agranoff, 
1987). Due to the complexity of the nervous system, 
the use of homogeneous cultured neurotumor cell lines, 
such as neuroblastomas and astrocytomas, has proved 
invaluable both in the identification of individual re- 
ceptor subtypes coupled to PPI turnover and in studies 
of their regulation. However, although the character- 
ization of several receptor subtypes linked to PPI turn- 
over has been facilitated by this approach, for other 
functionally linked receptors, few if any suitable neural 
cell lines are presently available. In the present study, 
we have investigated the presence of PPI-linked recep- 
tors on human SK-N-MC neuroepithelioma cells. Al- 
though previously designated as a neuroblastoma 
(Biedler et al., 1973), this cell line is more appropriately 
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defined as a neuroepithelioma (McKeon et al., 1988). 
The results indicate that SK-N-MC cells express at least 
four distinct receptors linked to PPI hydrolysis, one of 
which is the muscannic M I  subtype, previously iden- 
tified on a number of other neurotumor cell lines. In 
addition, a P2 nucleotide receptor is functionally linked, 
as well as two other receptor subtypes not yet estab- 
lished to  operate through enhanced PPI turnover in 
neural tissues, i.e., an alA-adrenergic receptor and an 
endothelin (ET) receptor subtype selectively activated 
by ET-1 and ET-2. 
MATERIALS AND METHODS 
SIC-N-MC cells (passage no. 42) were obtained from 
American Type Culture Collection (Rockville, MD, U.S.A.), 
myo-[2-3H]Inositol (15 Ci/mmol) was obtained from Amer- 
ican Radiolabeled Chemicals (St. Louis, MO, U.S.A.) or 
Amersham Corp. (Arlington Heights, IL, U.S.A.). The fol- 
lowing radiolabeled inositol phosphates [ 1-D-mJm-inOSitOl 
monophosphate (IP,), 1-Dmyo-inositol bisphosphate (IP*), 
1 -D-myo-inositol trisphosphate (IP3), and 1 -D-myo-inositol 
tetrakisphosphate (IP4)] were obtained from New England 
Nuclear (Boston, MA, U.S.A.): [2-3H]I( l)PI (5 Ci/mmol), [2- 
3H]I(4)PI (4.5 Ci/mmol), [2-3H]I( 1,4)Pz (4.5 Ci/mmol), [ 1- 
3H]I( 1,4,5)P3 (20 Ci/mmol), [ 1-3H]I( 1,3,4)P3 (1 7 Ci/mmol), 
and [2-’H]I( 1 ,3,4,5)P4 ( 5  Ci/mmol). (-)-Norepinephrine 
(NE), serotonin, histamine, Args-vasopressin, substance P, 
bombesin, neurotensin, ATP, ADP, GTP, ITP, XTP, UTP, 
AMP, adenosine, phenylephrine, bethanechol, arecoline, 
digitonin, and (-)-isoproterenol were obtained from Sigma 
Chemical Co. (St. Louis, MO, U.S.A.). Chloroethylclonidine, 
(-)-epinephrine (Epi) bitartrate, clonidine, WB-4 10 1, 5- 
methylurapidil, 6-fluonorepinephrine, prazosin, yohimbine, 
phentolamine, oxotremorine-M (0x0-M), adenosine 5‘-0-(2- 
thiodiphosphate) (ADPPS), and 2-methylthioadenosine 5’- 
triphosphate (2MeSATP) were purchased from Research 
Biochemicals, Inc. (Natick, MA, U.S.A.). Ionomycin and 
adenosine 5’-0-(3-thiotriphosphate) (ATP-y S) were purchased 
from CalBiochem (San Diego, CA, U.S.A.). ET-1, ET-2, and 
ET-3 were obtained from Peninsula Laboratories (Belmont, 
CA, U.S.A.). Phytic acid was purchased from Aldrich Chem- 
ical Co. (Milwaukee, WI, U.S.A.), and a partial hydrolysate 
was prepared as previously described (Heacock et al., 1990). 
Tissue culture supplies were obtained from Corning Glass 
Works (Coming, NY, U.S.A.). Powdered Dulbecco’s modi- 
fied Eagle’s medium and fetal bovine serum were purchased 
from GIBCO (Grand Island, NY, U.S.A.). Dowex-1 (100- 
200 mesh, X8 in the formate form) was obtained from Bio- 
Rad (Rockville Center, NY, U.S.A.). The pentaacetoxymethyl 
ester derivative of fura-2 (fura-2/AM) was obtained from 
Molecular Probes (Eugene, OR, U.S.A.). Pirenzepine and 11- 
[ [2-[(diethylamino)methyl]- 1 -piperidinyl]-acetyl]-5,1 l-dihy- 
dro-6H-pyrido[2,3b][ 1,4]benzodiazepin-6-one (AF-DX 1 16) 
were obtained from Boehringer-Ingelheim (Ridgefield, CT, 
U.S.A.). 
Cell culture conditions 
Human SK-N-MC neuroepithelioma cells (passage num- 
bers 43-67; Biedler et al., 1973) were grown in tissue culture 
flasks (75 cm2/250 ml) in 20 ml of Dulbecco’s modified Ea- 
gle’s medium supplemented with 10% (by volume) fetal bo- 
vine serum (medium I). Cells were grown for 5-14 days at 
37°C in an atmosphere consisting of 10% COz and 90% hu- 
midified air. Subculture was achieved by aspirating medium 
I and isolating the cells following incubation in a modified 
Puck‘s DI solution containing 0.5 mM EDTA and 0.05% 
trypsin (medium 11; Honegger and Richelson, 1976). (Al- 
though the use of trypsin was essential for efficient detachment 
of the neuroepithelioma cells, the possibility of its adverse 
effect on receptor-effector coupling events, while unlikely, 
cannot be excluded.) After centrifugation of the cell suspen- 
sion for 1 rnin at 300 g, the supernatant was removed and 
cells resuspended in 10 ml of medium I which was then in- 
oculated into flasks (one confluent flask into five to 10 flasks) 
on day 0. The culture medium was changed on day 4 and 
on alternate days thereafter by the addition of 10 ml of fresh 
medium I and removal of 10 ml of medium. 
Measurement of PPI turnover 
SK-N-MC cells were allowed to prelabel for 2-3 days in 
Dulbecco’s modified Eagle’s medium/ 10% fetal bovine serum 
containing 2.5- 10 pCi/ml [3H]inositol. In preliminary ex- 
periments, it was determined that a 24-h labeling period was 
sufficient for the lipids to attain an isotopic equilibrium of 
labeling. Cells were detached in medium I1 and washed twice 
in buffer A (142 mM NaC1, 5.6 mM KC1, 2.2 mM CaC12, 
3.6 mMNaHC03, 1 mMMgC12, 5.6 mM D-glucose, and 30 
mM sodium HEPES buffer, pH 7.4). Cells were then resus- 
pended in buffer A and incubated at 37°C in the presence 
of agonists and/or antagonists (final volume 0.5 ml). The 
accumulation of 3H-inositol phosphates was then monitored 
in the presence of Li+, as previously described (Thompson 
and Fisher, 1990). Unless stated otherwise, a 30-min incu- 
bation period was routinely employed. In some experiments, 
the individual inositol phosphate isomers were separated by 
HPLC and quantitated as previously described (Fisher et al., 
1990). Reactions were terminated by the addition of 2 ml of 
ice-cold 0.9% NaCl; the cells were centrifuged for 3 min at 
500 g and the supernatants removed by aspiration. To the 
cell pellets was added 0.5 ml of 5% trichloroacetic acid (TCA), 
and the tubes were left on ice for 20 min to allow precipitation 
of protein. Inclusion of 200 pg of phytate hydrolysate at this 
stage optimized the recoveries of IP3 and IP4 (Horstman et 
al., 1988). Inositol phosphate isomers present in neutralized 
TCA extracts were then separated on a Whatman Partisil 10 
SAX column. Radioactivity was monitored either on-line by 
means of a Beckman System Gold 17 1 Flow Counter, with 
an efficiency of 20-30% with Beckman Ready Flow 111 scin- 
tillation fluid (ratio of scintillant/eluate, 4: 1) or, alternatively, 
fmctions were collected and radioactivity determined directly 
by liquid scintillation counting. Inositol phosphate isomers 
were identified from the elution times of authentic radio- 
labeled standards, i.e., I( l)P1, I(4)PI, I( 1 ,4)P2, I( 1,3,4)P3, 
I( 1,4,5)P3, and I( 1,3,4,5)P4. 
Measurement of fura-2 efflux from SK-N-MC cells 
SK-N-MC cells were loaded with 1 pLM fura-2/AM for 15 
rnin at 37°C under conditions previously described for SK- 
N-SH cells (Fisher et al., 1989). The SK-N-MC cells were 
then washed twice with buffer A to remove excess fura-2/ 
AM and resuspended in fresh buffer A. Aliquots of fura-2- 
loaded SK-N-MC cells were then allowed to incubate at 37°C 
for 30 min in the presence or absence of 1 mM ATP. At the 
end of this time interval, cells were centrifuged at 300 g for 
5 rnin and supernatants collected. Fluorescence of superna- 
tants (&itation = 340 nm, &,ision = 490 nm) was monitored 
in a Shimadzu spectrophotofluorometer. The release of fura- 
2 was calculated as a percentage of dye initially present (ob- 
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tained from supernatant fluorescence following the addition 
of 10 pM digitonin). The concentration of free Ca" in buffer 
solutions was determined directly by fura-2 (free acid) fluo- 
rescence (Fisher et al., 1989). Protein was determined by the 
method of Geiger and Bessman (1 972). 
Data analysis 
Values quoted are means k SEM for the number of sep- 
arate experiments performed. Student's two-tailed t tests were 
used to evaluate the statistical differences of the means of 
unpaired sets of data. The release of inositol phosphates is 
expressed as a percentage of control and is calculated from 
the equation: 
A - Z  
B - Z  inositol phosphate release = x 100 
where A and Bare the values obtained for inositol phosphate 
release in the presence of the agonist (A) or absence of the 
agonist (B) after a 30-min incubation period, and Z is inositol 
phosphate release obtained at zero time. Calculation of an- 
tagonist inhibition constants were derived from the equation: 
Ki = ICso/( 1 + [A]/ECso), where ICso is the concentration of 
antagonist required for a 50% inhibition, [A] is the agonist 
concentration, and ECSo is the concentration of agonist re- 
quired for half-maximal stimulation of PPI turnover (Cheng 
and Prusoff, 1973). The Ki values so obtained are apparent 
in that two assumptions are made: (a) a competitive inter- 
action exists between the agonist and antagonist, and (b) there 
is an absence of any substantial receptor reserve for PPI turn- 
over. In all situations examined to date, the second assump- 
tion holds true (Fisher and Agranoff, 1987). Dose-response 
and dose-inhibition curves were analyzed by the GraphPad 
InPlot curve-fitting program. 
RESULTS 
Biochemical characteristics of ligand-activated PPI 
hydrolysis in SK-N-MC cells 
Of 11 ligands tested, the addition of optimal con- 
centrations of four, i.e., NE, 0x0-M, ET-1, and ATP, 
each elicited an increased release of 'H-inositol phos- 
phates from SK-N-MC cells that had been allowed to 
label to isotopic equilibrium with ['HJinositol (Table 
1). Stimulation of PPI turnover by these agonists, al- 
though variable in magnitude between experiments, 
was observed consistently. In contrast, the addition of 
serotonin, histamine, quisqualate, vasopressin, sub- 
stance P, bombesin, or neurotensin had little or no 
effect on inositol phosphate release. Activation of PPI 
turnover by each of the four active ligands required 
the addition of Ca2+ for a full effect. Thus, when Ca" 
was omitted from the incubation medium (free Ca2' - 1 pM),  the stimulation of 'H-inositol phosphate re- 
lease elicited by the addition of NE, 0x0-M, ET- 1, and 
ATP was inhibited by 36 f 9%, 56 -t 5%, 57 f 6%, 
and 57 -t 12%, respectively (n = 3). When 1 mMEGTA 
was added, stimulated PPI turnover was inhibited fur- 
ther (data not shown). The addition of 10 pM iono- 
mycin also increased the release of inositol phosphates 
to 351 k 83% of control (n = 4). 
Both basal and agonist-stimulated inositol phosphate 
release proceeded approximately linearly with time 
TABLE 1. Ligand-stimulated 'H-inositol phosphate 
formation in SK-N-MC cells 
Release of inositol 
phosphates 












723 f 49 (n = 48) 
879 f 88 (n = 30) 
678 f 61 (n = 19) 
401 f 34 (n = 20) 
94-C 1 3 ( n = 4 )  
128 -C 21 (n = 4) 
97 k 10 (n = 3) 
112 1- 20 (n = 3) 
1 1 8 k 7  ( n = 3 )  
9 2 2 9  (n = 3) 
1 1 4 k  1 1  (n = 3) 
Prelabeled SK-N-MC cells (- 1 mg of protein) were incubated for 
30 min at 37" with the ligands as indicated. Reactions were terminated 
by the addition of an equal volume of 20% TCA, and labeled inositol 
phosphates present in the neutralized TCA extracts were quantitated 
by anion-exchange chromatography. Results are expressed as release 
of inositol phosphates relative to control incubations for the number 
of separate experiments indicated. 
over a 60-min period with no evidence of receptor de- 
sensitization (Fig. 1). Unless stated otherwise, a 30- 
min incubation time was chosen routinely. Although 
the release of a total inositol phosphate fraction was 
monitored routinely, in some experiments the individ- 
ual inositol phosphate isomers present were also iden- 
tified by HPLC (Fig. 2). All four agonists elicited an 
increased release of [3H]I( 1/3)P1 (an enantiomeric pair), 
['H]1(4)P,, ['H]IP2, ['H]1(1,3,4)P3, and ['HIIP,, the 
largest increases (on a fold basis) being observed for 
I( 1/3)PI, I(4)PI, I( 1,3,4)P3, and IP4 (Table 2). An in- 
creased release of labeled I( 1 ,4,5)P3 was observed fre- 
quently, but not consistently, at the 30-min time point 
selected. 
Pharmacological identification of receptor subtypes 
coupled to PPI turnover 
Adrenergic. The addition of either NE or Epi to SK- 
N-MC cells resulted in a concentration-dependent in- 
crease in 'H-inositol phosphate release (Fig. 3). The 
ECso for NE was 6.3 k 0.7 p M  (n = 3), whereas that 
for Epi was 2 pM(n = 2). As previously noted for brain 
slices (Minneman and Johnson, 1984), Epi was found 
consistently to be a more efficacious agonist than NE. 
Other adrenergic agonists, such as 6-fluonorepi- 
nephrine and phenylephrine (selective for the aI sub- 
type), were partial agonists for stimulated PPI turnover. 
Neither the addition of the a2-selective agonist cloni- 
dine nor the P-selective agonist isoproterenol stimu- 
lated PPI hydrolysis (Table 3). Further evidence for the 
involvement of an a I-receptor subtype was obtained 
from antagonist studies. Addition of phentolamine, a 
nonselective a antagonist, blocked NE-stimulated PPI 
turnover with a Ki of 1 1 nM. In contrast, the a2-selec- 
tive antagonist yohimbine inhibited with a 38-fold 
lower potency (Ki = 4 16 nM; Fig. 4). Because at least 
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Time (minutes) 
FIG. 1. Time course of basal and ligand-stimulated 3H-inositol 
phosphate formation. Prelabeled SK-N-MC cells (-1 rng of protein) 
were incubated in either the absence (basal) or presence of NE (1 
mnn), 0x0-M (1 mM), ET-1 (0.5 pM), or ATP (1 mnn) for the times 
indicated at 37°C. Reactions were terminated by the addition of 
an equal volume of 20%0 TCA, and a total inositol phosphate fraction 
present in neutralized extracts was quantitated by anionexchange 
chromatography. Values shown are means of triplicate determi- 
nations (SEM < 10% of means). 
two al-receptor subtypes (alA and a l ~ )  can now be 
differentiated on the basis of antagonist potency, we. 
evaluated the abilities of WB-4101, prazosin, and 5- 
methylurapidil to block NE-stimulated inositol phos- 
phate formation. All three antagonists were potent in- 
hibitors. 5-Methylurapidil (Ki = 2.2 nM), which ex- 
hibits most selectivity for the alA subtype (Hanft and 
Gross, 1989), was almost as effective as either prazosin 
(K,  = 0.6 nM) or WB-4101 (Ki = 0.9 nM) in inhibiting 
the PPI response (Fig. 5). The Hill coefficients for in- 
hibition were close to 1 (0.84-0.98), indicating that 
these antagonists bound predominantly to a single form 
of the receptor. The alA and alB subtypes have also 
been differentiated on the basis of their susceptibilities 
to the alkylating agent chloroethylclonidine, the alB 
subtype exhibiting a greater sensitivity (Han et al., 




I ll I\ 0x0-M 1 
322 27 37 41 57 63 
Time (min) 
FIG. 2. HPLC separation of inositol phosphate isomers. Prelabeled 
SK-N-MC cells (-5 mg of protein) were incubated for 30 min at 
37°C in either the absence (basal) or presence of NE (1 mM) or 
0x0-M (1 mM). Reactions were terminated by the addition of ice- 
cold 0.9O/0 NaCI; cells were centrifuged and supernatants removed 
by aspiration. lnositol phosphates were extracted from the cell 
pellets following the addition of 5% TCA (and 200 pg of phytate 
hydrolysate), and isomers present in the neutralized TCA extracts 
were separated by HPLC. Elution patterns shown are from one of 
three experiments that gave similar results. The isomer profiles 
obtained for ET-1 and ATP were qualitatively similar to those of 
NE and 0x0-M. Note that increases in l(1 ,4,5)P3 were not observed 
consistently, whereas increases in l(1/3)P1, 1(4)P1, IP2, 1(1,3,4)P3, 
and IP4 were always detected. 
chloroethylclonidine for 30 min resulted in a modest 
(36%) inhibition of NE-stimulated 3H-inositol phos- 
phate release in SK-N-MC cells (Table 4). Although 
neither ET- 1- nor ATP-stimulated PPI turnover was 
influenced by chloroethylclonidine pretreatment, there 
was a 2 1 % reduction of 0x0-M-stimulated inositol 
TABLE 2. HPLC separation and quanfitation of inositol phosphate isomers formed in SK-N-MC cells 
Radioactivity (cpm) 
Basal NE 0x0-M ET- 1 ATP 
1(1/3)Pi 6,288 f 241 23,042 t 689 46,715 f 1069 21,951 t 572 14,938 t 444 
1(4)P, 314 f 314 6,489 k 506 15,898 ? 1178 5,835 k 336 2,806 k 2 12 
4,920 f 384 IP2 
I( 1,3,4)P3 298 f 54 1,088 * 16 1,977 k 79 709 f 22 461 t 2 0  
I(1,4S)P3 517 f 44 751 k 42 1,120 * 36 645 k 62' 526 t 66" 
IP.3 693 t 102 2,132 t 86 3,822 f 180 1,513 f 49 1,247 t 33 
3,175 f 410 6,413 f 443 14,832 k 1090 5,070 f 314 
SK-N-MC cells were prelabeled with [3H]inositol (10 pCi/ml) for 3 days. Cells (-5 mg of protein) were incubated 
with either NE (1 mM), 0x0-M (1 mM), ET-1 (0.5 M), or ATP (1 mM) for 30 min. Reactions were terminated by 
the addition of ice-cold 0.9% NaCI; cells were centrifuged and supernatants removed by aspiration. Inositol phosphates 
were extracted from the cell pellets following the addition of 5% TCA (and 200 fig of phytate hydrolysate), and isomers 
present in the neutralized TCA exctracts were separated by HPLC. Results shown are means + SEM for triplicate 
determinations from one of three experiments that gave similar results. For all four agonists, the release of individual 
inositol phosphate isomers was statistically different from that obtained for control incubations ( p  < 0.05), with the 
exception of those instances marked with an a. 
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FIG. 3. Concentration dependence of NE- and Epi-stimulated ino- 
sitol phosphate formation. SK-N-MC cells were incubated in either 
the absence (0, basal) or presence of NE or Epi at the indicated 
concentrations for 30 min at 37°C. Reactions were terminated and 
inositol phosphates quantitated as described in the legend to Fig. 
1. Values shown are means of triplicate determinations (SEM < 5% 
of mean). The calculated ECJo values were 2 and 4 ~L.M for Epi and 
NE, respectively. The corresponding Hill coefficients were 0.99 
and 1 . 1 1 , respectively. 
phosphate formation, indicating that the effects of al- 
kylation may not be restricted solely to the adrenergic 
receptor in this cell line. 
Muscarinic cholinergic. Addition of 0x0-M resulted 
in a concentration-dependent increase in inositol 
phosphate release with an ECso value of 20 k 3 pM (n 
= 4). Bethanechol (10 mM) and arecoline (1 mM) 
were partial agonists (276 f 80% and 202 k 62% of 
control, respectively; n = 3). Pirenzepine, an M,-se- 
lective antagonist, potently inhibited Oxo-M-stimu- 
lated PPI turnover (Ki = 35 nM). In contrast, AF-DX 
1 16, an antagonist selective for Mz receptors, inhibited 
with a 30-fold lower affinity (Ki = 1.04 ~, Fig. 6). 
ET. Of the three ETs tested, ET-1 and ET-2 were 
markedly more effective activators of PPI hydrolysis 
in SK-N-MC cells than ET-3. Thus, at a concentration 
of 0.5 pM, addition of ET-1 increased the release of 
3H-inositol phosphates to 678 f 61% of control (Table 
1 ), whereas the corresponding values obtained for ET- 
2 and ET-3 were 621 k 78% (n = 6) and 154 k 15 (n 
= 4), respectively. The ECso values obtained for ET- 1 
and ET-2 were similar (- 10 M, Fig. 7). When both 
ET-1 and ET-2 were present in the incubations, no 
further increase in inositol phosphate release was ob- 
served compared with that obtained in the presence of 
either alone, indicating that both ligands interact with 
a common receptor site (Fig. 8). Inclusion of 0.5 pM 
ET-3 did not reduce the effectiveness with which either 
ET- 1 or ET-2 stimulated PPI hydrolysis, indicating that 
at this concentration ET-3 does not behave as a com- 
petitive partial agonist. 
Nucleotide. The addition of ATP resulted in a dose- 
dependent increase in 3H-inositol phosphate release 
with an ECso value of - 100 pM. 2MeSATP, a putative 
Pzy purinergic agonist, also enhanced PPI turnover with 
a potency similar to that obtained for ATP (Fig. 9). 
ATPyS, ADP, and ADPpS were also effective (Table 
5). A combination of 1 mM ATP plus 1 mM ADP did 
not result in a stimulation of PPI turnover greater than 
that elicited by ATP alone. Other purine nucleotides, 
such as GTP, ITP, and XTP, were able to promote 
PPI turnover, as was the pyrimidine UTP. AMP was 
only marginally effective, whereas adenosine was in- 
active, thereby excluding the involvement of a PI pur- 
inoceptor. The addition of ATP (but not other purine 
nucleotides) can induce a generalized increase in per- 
meability of cell plasma membranes due to the for- 
mation of ATP- (Cockcroft and Gomperts, 1979; 
TABLE 3. Differential effects of adrenergic agonists on PPI turnover 
in SK-N-MC cells 
Release of inositol phosphates 
% of NE 











1 m M  
1 m M  
0.1 m M  
1 m M  
0.1 mM 
1 m M  
0.1 mM 
1 m M  
10 N 
0.1 mM 
723 f 49 (48)' 
1,113 + 170 (6) 
478 f 192 (3) 
459 f 7 8  (4) 
339 + 7 6  (5) 
2 7 2 f 7 3  (5) 
118-t 19 (3) 
99 + 40 (3) 
109 f 37 (3) 
141 f 36 (3) 
(100) 
149 f 7 
51 f 5  
38 k 6 
33 f 6 
27 f 4 
4 f 4  
5 f 5  
6 2 5  
10+7 
SK-N-MC cells (- 1 mg of protein) were incubated for 30 min at 37°C in either the 
absence or presence of the adrenergic ligands indicated. Reactions were terminated 
and inositol phosphates quantitated as described in the footnote to Table 1 .  Results 
are expressed either as release of inositol phosphates relative to control incubations or, 
alternatively, as the release relative to that obtained for NE in the same experiment. 
The number of separate experiments performed is indicated in parentheses. 
Data taken from Table 1.  
J. Neurochem., Vol. 57, No. 5, 1991 
1604 S. K. FISHER AND R. E. LANDON 
8 7 6 5 4  
-log [Antagonist] (M) 
FIG. 4. Phentolamine and yohimbine inhibition of NE-stimulated 
PPI turnover in SK-N-MC cells. SK-N-MC cells were incubated for 
30 min at 37°C in the presence of 1 mM NE and phentolamine or 
yohimbine at the concentrations indicated. Results are expressed 
as percentage of maximum response (obtained with NE alone) as 
a function of antagonist concentration. Values shown are the means 
+_ SEM for three to four separate experiments. Neither phentol- 
amine nor yohimbine had any effect on 3H-inositol phosphate re- 
lease when added alone at the highest concentration used. The 
calculated K, values for phentolamine and yohimbine were 11 and 
41 6 nM, respectively. The corresponding Hill coefficients were 0.85 
and 0.94, respectively. 
Greenberg et al., 1988). To determine whether SK-N- 
MC cells became leaky in the presence of ATP, the 
release of fura-2 (from dye-loaded cells) into extracel- 
lular fluid was monitored. Over a 30-min incubation 
period at 37"C, 53 f 7% of total fura-2 initially loaded 
into control cells leaked into the surrounding medium. 
In the presence of ATP, no further increase in fura-2 
leakage occurred (51 f 7%, n = 3). 
DISCUSSION 
The selective ability of four groups of pharmacolog- 
ically distinct ligands to enhance inositol lipid turnover 
O h  
9 8 7 6 5  9 8 7 6 5  9 0 7 6 5  
-log [Antagonist] (M) 
FIG. 5. WB-4101, prazosin, and 5-methylurapidil inhibition of NE- 
stimulated PPI turnover. SK-N-MC cells were incubated for 30 min 
at 37°C in the presence of 1 mM NE and the antagonists at the 
concentrations indicated. Results are expressed as percentage of 
maximum response (obtained with NE alone) as a function of an- 
tagonist concentration. Values shown are the means * SEM for 
four or five separate experiments. Where no error bar is shown, 
the SEM fell within the symbol. The calculated K, values for WB- 
4101, prazosin, and 5-methylurapidil were 0.6, 0.9, and 2.2 nM, 
respectively. The corresponding Hill coefficients were 0.84, 0.96, 
and 0.98, respectively. 
TABLE 4. Effect of chloroethylclonidine pretreatment 
on agonist-stimulated PPI turnover 
Release of inositol phosphates 





64 f 2" (4) 
79 f I "  (4) 
102 * 6 (3) 
118 * 14 (3) 
SK-N-MC cells were incubated in the presence of 50 p M  chloro- 
ethylclonidine or buffer A for 30 min at 37°C. Both groups of cells 
were then washed twice with buffer A and challenged with either NE 
( 1  mM), 0x0-M ( 1  mM), ET-1 (0.5 I M ) ,  or ATP (1 mM) for 30 
min at 37°C. Reactions were terminated and inositol phosphates 
quantitated as described in the footnote to Table 1. Results are ex- 
pressed as stimulated inositol phosphate release obtained in the chlo- 
roethylclonidine-treated cells relative to that observed for control 
cells. The number of separate experiments performed is indicated in 
parentheses. 
' Statistically different from untreated cells (p < 0.02). 
indicates the presence of multiple PPI-linked receptors 
on SK-N-MC cells, the characteristics of which are dis- 
cussed below. Although increases in I( 1,4,5)P3 pro- 
duction were not robust, it appears likely that the ad- 
dition of each ligand promotes the Ca*+-dependent hy- 
drolysis of polyphosphoinositides, as evident from the 
stimulated formation of I(4)P1, IP2, I( 1 ,3,4)P3, and IP4. 
The minimum contribution of polyphosphoinositides 
to inositol phosphate production (36-45%) can be cal- 
culated from the sum of radioactivities associated with 
these inositol phosphate isomers. However, because this 
calculation ignores [3H]I( 1/3)P1 formed from sequen- 
tial dephosphorylations of I( 1,3,4)P3 (Shears, 1989), it 
is likely to be an underestimate of the true contribution 












9 8 7 6 5 4 3  
-log [Antagonist] (M) 
FIG. 6. Pirenzepine and AF-DX 11 6 inhibition of Oxo-M-stimulated 
inositol phosphate formation. SK-N-MC cells were incubated for 
30 min at 37°C in the presence of 0.1 mM 0x0-M and the antag- 
onists at the concentrations indicated. Results are expressed as 
percentage of maximum response (obtained with 0x0-M alone) as 
a function of antagonist concentration. Values shown are means 
k SEM for three separate experiments. The calculated K, values 
for pirenzepine and AF-DX 116 were 35 nM and 1.04 pM,  respec- 
tively. The corresponding Hill coefficients were 1.02 and 1.1 0, re- 
spectively. Inset: Dose-response curve for 0x0-M. Maximum 
stimulation of inositol phosphate release was obtained at an agonist 
concentration of 1 mM. 
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-log [Endothelin] (M) 
FIG. 7. Differential effects of ETs on PPI turnover. SK-N-MC cells 
were incubated for 30 min at 37°C in either the absence (m, basal) 
or presence of ET-1, ET-2, or ET-3 at the concentrations indicated. 
Reactions were terminated and inositol phosphates quantitated 
as described in the legend to Fig. 1. Values shown are means of 
triplicate determinations (SEM < 5% of mean) for one of two ex- 
periments that gave similar results. The calculated ECS0 values for 
ET-1 and ET-2 were 7 and 15 nM, respectively. 
I( 1 ,3,4)P3 is sustained in SK-N-MC cells and, therefore, 
the 3'-kinase pathway of I( 1 ,4,5)P3 metabolism appears 
to operate continuously. As a consequence, IPls sub- 
sequently formed would be expected to accumulate 
steadily in the I( 1/3)P1 fraction in the presence of Li+. 
Thus, although the possibility of some direct break- 
down of phosphatidylinositol [and hence the formation 
of I( 1)P,] cannot be discounted, the polyphosphoino- 
sitides appear to be a primary source of inositol phos- 
phates in SK-N-MC cells. A similar conclusion as to 
the lipid origin of stimulated inositol phosphate for- 
mation has been drawn recently for parotid glands 
(Hughes and Putney, 1989), brain slices (Batty and 
Nahorski, 1989), and SK-N-SH neuroblastoma cells 
(Fisher et al., 1990). The Ca2+dependence ofstimulated 
E T - 1 -  + - - + + - + 
E T - 2 -  - + - + - + + 
E T - 3 -  - - + - + + + 
FIG. 8. Lack of additivity between ET-1, ET-2, and ET-%stimulated 
inositol phosphate formation. SK-N-MC cells were incubated for 
30 min at 37°C in either the absence or presence of 0.5 pM con- 
centrations of ET-1, ET-2, and ET-3 as indicated. Reactions were 
terminated and inositol phosphates quantitated as described in the 
legend to Fig. 1. Values shown are the means 5 SEM for triplicate 
determinations obtained in a single experiment. Similar results were 
obtained in a further four experiments. Note that the stimulations 
of PPI turnover elicited by ET-1 and ET-2 are not additive, whereas 
inclusion of ET-3 does not block the more efficacious ETs, ET-1 
and ET-2. 
I 2MeSATP 1 ATP 
-6 5 4 3 2 6 5 4 3 ' 2  
-log (Agonist] (M) 
FIG. 9. Both ATP and the putative Pa agonist 2MeSATP stimulate 
inositol phosphate formation. SK-N-MC cells were incubated for 
30 min at 37°C in either the absence (B, basal) or presence of 
either ATP or 2MeSATP at the concentrations indicated. Reactions 
were terminated and inositol phosphates quantitated as described 
in the legend to Fig. 1. Values shown are means of triplicate rep- 
licates (SEM < 5% of mean) for one of three experiments (ATP) 
or two experiments (2MeSATP) that gave similar results. The cal- 
culated ECW values in the experiment shown were 47 and 121 FM 
for 2MeSATP and ATP, respectively. 
PPI turnover observed for SK-N-MC cells is similar to 
that previously reported for SK-N-SH neuroblastoma. 
In the latter cells, phospholipase C activity is regulated 
by changes in intracellular Ca2+, and a continuous in- 
flux of Ca2+ is proposed to facilitate PPI hydrolysis 
(Fisher et al., 1989). 
There is now compelling evidence for the involve- 
ment of al-adrenergic receptors in stimulated PPI 
turnover in brain (Brown et al., 1984; Minneman and 
Johnson, 1984; Schoepp et al., 1984). Similarly, in SK- 
N-MC cells, an increased PPI hydrolysis is elicited by 
the addition of the a1 agonist phenylephrine, but not 
TABLE 5. Effect of purinergic nucleotides on inositol 
phosphate formation in SK-N-MC cells 
Release of inositol phosphates 












401 k 34 (20)" 
256 + 31 (3) 
343 + 46 (4) 
298 t 56 (3) 
355 f 46 (4) 
292 t 59 (3) 
277 f 45 (3) 
308 f 65 (3) 
296 t 57 (3) 
182 + 20 ( 5 )  
108 + 15 ( 5 )  
( 100) 
7 1 k 3  
86 f 10 
68 -t 10 
88 & 8 
68 -t 5 
65 + 1 
14 + 6 
70 k 3 
30 + 3 
6 + 3  
SK-N-MC cells (- I mg of protein) were incubated for 30 min at 
37°C in either the absence or presence of the ligands indicated (all 
at a I mM concentration). Reactions were terminated and inositol 
phosphates quantitated as described in the footnote to Table 1. Results 
are expressed either as release of inositol phosphates relative to control 
incubations or, alternatively, the release relative to that obtained for 
ATP in the same experiment. The number of separate experiments 
performed is indicated in parentheses. 
Data taken from Table 1 .  
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by the a2 agonist clonidine or the /3 agonist isoproter- 
enol. However, two distinct differences can be discerned 
for adrenergic stimulation of inositol lipid hydrolysis 
in SK-N-MC cells from that in brain. First, relative to 
that of NE, the efficacies of the two al-selective agonists 
phenylephrine and 6-fluonorepinephrine (27-5 1 %; 
Table 3) are markedly less than those observed for brain 
(62-94%; Johnson and Minneman, 1986; Minneman, 
1988). Second, from antagonist studies, the functional 
coupling of an alA receptor is indicated for SK-N-MC 
cells, rather than the aIB subtype prei4ously implicated 
in cerebral cortex (Minneman, 1988; Michel et al., 
1990). The two a1 subtypes can be distinguished phar- 
macologically on the basis of (a) 10- and 70-fold greater 
affinities of the competitive antagonists WB-4 101 and 
5-methylurapidil, respectively, for the atA subtype (KD - 1 nM, Minneman, 1988; Hanft and Gross, 1989), 
and (b) a greater susceptibility of the a l B  subtype to 
irreversible blockade by chloroethylclonidine (I& - 1 
pLM, Minneman, 1988). In SK-N-MC cells, NE-stim- 
ulated PPI turnover is inhibited potently by both WB- 
4101 and 5-methylurapidil ( K  < 2.5 nM), whereas only 
a modest inhibition of inositol lipid hydrolysis occurs 
following preincubation of the cells with a high con- 
centration of chloroethylclonidine. The antagonist 
profile of NE-stimulated PPI turnover in SK-N-MC 
cells and its susceptibility to alkylation are very similar 
to those recently observed for alA receptors identified 
on renal cells (Han et al., 1990). The present results, 
together with those from a recent study with cultured 
glial cells (Wilson and Minneman, 1990u), indicate that 
both and (YIB subtypes are linked to PPI hydrolysis 
in neural tissues. Although it has been suggested that 
activation of alA receptors may result in the breakdown 
of phosphatidylinositol rather than of the polyphos- 
phoinositides (Wilson and Minneman, 1990b), such 
appears not to be the case for the same receptors on 
SK-N-MC cells. 
From transfection studies, at least three muscarinic 
receptor subtypes (MI, M3, and M,) are known to cou- 
ple to PPI turnover (Bonner et al., 1988; Ashkenazi et 
al., 1989). Only two of these subtypes (MI and M3) 
have been demonstrated to be functionally linked in 
the CNS and neural-related tissues (Fisher and Agran- 
of€, 1987, and references therein; Ellis et al., 1990; For- 
ray and El-Fakahany, 1990). Muscarinic acetylcholine 
receptors linked to PPI turnover in SK-N-MC cells ap- 
pear to be predominantly of the MI subtype, because 
pirenzepine inhibited the response with a Ki of 35 nM, 
a value that is close to its affinity binding constant to 
MI receptors in neural tissues (Watson et al., 1983) 
and similar to that obtained for inhibition of PPI turn- 
over in other MI-enriched neural preparations (Gon- 
zales and Crews, 1984; Fisher and Bartus, 1985). AF- 
DX 116, an antagonist selective for M2 receptors, in- 
hibits with a 30-fold lower potency in SK-N-MC cells. 
In contrast, M3 receptors (such as those on SK-N-SH 
and 132 1 N 1 cells) are inhibited relatively weakly by 
both pirenzepine and AF-DX 1 16 (Fisher and Heacock, 
1988; Kunysz et al., 1989). The potency with which 
0x0-M stimulated inositol phosphate formation in SK- 
N-MC cells and the relative efficacies of the partial ag- 
onists bethanechol and arecoline are similar to those 
previously observed for the MI-muscarinic acetylcho- 
line receptor linked to PPI turnover in brain and in 
NIE-115 cells (Fisher et al., 1984; Fisher and Snider, 
1987). 
High-affinity binding sites for the ETs (and their 
structural homologues, the sarafotoxins) have been 
identified recently in the CNS (Kloog et al., 1988; Jones 
et al., 1989). Moreover, the functional coupling of these 
sites to PPI turnover has been demonstrated for a 
number of brain regions (Kloog et al., 1989b; Mac- 
Cumber et al., 1990). In SK-N-MC cells, the addition 
of ET- 1 elicits an increase in PPI turnover comparable 
in magnitude to that observed in brain. However, a 
notable difference is the inability of ET-3 either to en- 
hance PPI turnover in SK-N-MC cells by itself or to 
block the effects of ET-1 and ET-2. In contrast, ET-3 
is a full agonist in brain, C6 glioma, and primary neu- 
ronal cultures (Crawford et al., 1990; Lin et al., 1990; 
MacCumber et al., 1990). This result raises the possi- 
bility that more than one functionally linked subtype 
of ET receptor may exist. In keeping with this sugges- 
tion, Moog et al. ( 1989~) have identified three subtypes 
of the ET receptor on the basis of radioligand binding 
data. Whereas both ET-1 and ET-3 readily bind to the 
E-SP and E-Sr subtypes (found in cerebellum and cau- 
date, respectively), only ET- l binds to the E-Sa subtype 
(found in smooth muscles and aorta). Furthermore, 
two cDNAs encoding separate ET receptors have re- 
cently been cloned and expressed in host cells (Arai et 
al., 1990; Sakurai et al., 1990). One of the receptors 
(ETA) shows a high specificity for ET- 1, whereas the 
second (ETB) recognizes ET-1 and ET-3 with equal 
affinity. Although further characterization is necessary, 
the profile of agonist selectively obtained for stimula- 
tion of PPI turnover in SK-N-MC cells is consistent 
with the involvement of an ET receptor subtype Qstinct 
from those previously described in the CNS. 
A fourth receptor linked to PPI turnover in SK-N- 
MC cells is activated by the presence of ATP and other 
purine nucleotides. Because neither AMP nor adeno- 
sine exerted a substantial stimulatory effect on inositol 
lipid hydrolysis, the receptors involved appear to be of 
the P2 subtype (Burnstock and Kennedy, 1985). P2 re- 
ceptors linked to PPI turnover have also been dem- 
onstrated in astrocytes (Pearce et al., 1989), pituitary 
cells (Davidson et al., 1990), and adrenal chromaffin 
cells (Sasakawa et al., 1989; Allsup and Boarder, 1990). 
In SK-N-MC cells, all purine nucleotide triphosphates 
tested were able to promote PPI turnover, indicating 
a broad agonist specificity. However, given the ability 
of the pyrimidine UTP to enhance inositol phosphate 
release in this cell line and in other tissues (Fine et al., 
1989; Sasakawa et al., 1989), it may be more appro- 
priate to term the receptor involved a “nucleotidocep- 
tor” (Pfeilschifter, 1990). Of the P2-receptor subtypes 
J. Neurochem., Voi. 57, No. 5, 1991 
PPI HYDROLYSIS IN NEUROEPITHELIOMA CELLS 1607 
thus far described, it is the PZy receptor that has been 
linked to activation of PPI turnover in nonneural tis- 
sues (Martin and Harden, 1989; Allsup and Boarder, 
1990), based largely upon the potency exhibited by the 
putative P2,-selective agonist 2MeSATP for both bind- 
ing to the receptor and eliciting a functional response. 
However, although 2MeSATP and ATP are equally 
effective enhancers of PPI hydrolysis in SK-N-MC cells, 
they are also equipotent (Fig. 9). Furthermore, 
2MeSATP has been reported to be either a partial ag- 
onist (Pfeilschifter, 1990) or devoid of activity (Fine et 
al., 1989) at P2 receptors linked to PPI hydrolysis. These 
observations raise the possibility that the current def- 
inition of P2 subtypes is inadequate to account fully 
for the observed properties of this class of receptors. 
In conclusion, the present results indicate that SK- 
N-MC cells possess multiple PPI-linked receptors, two 
of which (alA-adrenergic and ET) have received little 
previous attention. The availability of this cell line may 
facilitate future studies of both the characterization and 
regulation of these receptors. 
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